ArticleFrontiers in oncology2022
FCGR3A: A new biomarker with potential prognostic value for prostate cancer.
Zeyu Zha et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleFrontiers in oncology2022
Zeyu Zha et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.